FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W40772017> ?p ?o ?g. }

• W40772017 endingPage "93" @default.
• W40772017 startingPage "788" @default.
• W40772017 abstract "Viperine snake bites cause hemotoxicity in the form of coagulation dysfunction. Optimal dose requirement of anti-snake venom (ASV) and duration of therapy in such situation have not yet been fully explored. Our aim in this study was to compare two low-dose continuous infusion regimes with the standard high dose intermittent bolus regime in treating systemic envenomation and preventing its recurrence.A prospective interventional study was conducted on 90 adult patients with snake bite with hemotoxicity. Patents were allocated into three treatment regimes, each regime being tried on 30 patients. Regimen I (standard high dose regimen) consisted of conventional, intermittent bolus dosage of 100 ml of ASV as a loading dose followed by 50 ml every six hours till whole blood coagulation time (CT) became normal. Regimen II consisted of 30 ml of ASV as a loading dose followed by 30 ml continuous infusion every six hours till two CTs at an interval of six hours were normal and a further dose of 30ml over 24 hours. Regimen III was similar to Regimen II in all aspects except that loading dose was 70 ml (instead of 30 ml).In patients with mild envenomation, even though the average requirement of ASV was only marginally lower in Regimen II (128.6 ml) as compared to in Regimen I (137.5 ml), one patient on Regimen I had relapse of coagulation dysfunction. In patients with moderate envenomation, average requirement of ASV was 221.3 ml and 179 ml in Regimens II and III respectively, which was much less than in Regimen I (343.8 ml) (p values 0.05 and 0.01 respectively). Further, no patient receiving Regimen III had relapse of coagulation dysfunction. In severe envenomation, average dose of ASV required was almost similar in Regimens II and III, i.e., 213.7 ml and 233.7 ml respectively, as compared to 433.3 ml required in Regimen I (p values 0.02 and 0.001 respectively). However, time lapse for CT normalization was only 18 hours in Regimen III as compared to 23.6 hours and 24 hours in Regimens I and II respectively.Regimens consisting of continuous intravenous infusion of ASV i.e., Regimen II in mild envenomation and Regimen III in moderate and severe envenomation are likely to make significant saving of ASV and reduction of recurrence of coagulation dysfunction." @default.
• W40772017 created "2016-06-24" @default.
• W40772017 creator A5021478438 @default.
• W40772017 creator A5036364679 @default.
• W40772017 creator A5050534693 @default.
• W40772017 creator A5061271648 @default.
• W40772017 date "2004-10-01" @default.
• W40772017 modified "2023-09-30" @default.
• W40772017 title "Rational use of anti-snake venom (ASV): trial of various regimens in hemotoxic snake envenomation." @default.
• W40772017 cites W120410299 @default.
• W40772017 cites W136672111 @default.
• W40772017 cites W1608858185 @default.
• W40772017 cites W1924301344 @default.
• W40772017 cites W1969404699 @default.
• W40772017 cites W2073053313 @default.
• W40772017 cites W2107043311 @default.
• W40772017 cites W2200879431 @default.
• W40772017 cites W2222156226 @default.
• W40772017 cites W2411805393 @default.
• W40772017 cites W2413713396 @default.
• W40772017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15909856" @default.
• W40772017 hasPublicationYear "2004" @default.
• W40772017 type Work @default.
• W40772017 sameAs 40772017 @default.
• W40772017 citedByCount "19" @default.
• W40772017 countsByYear W407720172012 @default.
• W40772017 countsByYear W407720172013 @default.
• W40772017 countsByYear W407720172014 @default.
• W40772017 countsByYear W407720172015 @default.
• W40772017 countsByYear W407720172017 @default.
• W40772017 countsByYear W407720172018 @default.
• W40772017 countsByYear W407720172022 @default.
• W40772017 countsByYear W407720172023 @default.
• W40772017 crossrefType "journal-article" @default.
• W40772017 hasAuthorship W40772017A5021478438 @default.
• W40772017 hasAuthorship W40772017A5036364679 @default.
• W40772017 hasAuthorship W40772017A5050534693 @default.
• W40772017 hasAuthorship W40772017A5061271648 @default.
• W40772017 hasConcept C141071460 @default.
• W40772017 hasConcept C145600735 @default.
• W40772017 hasConcept C18903297 @default.
• W40772017 hasConcept C2779448229 @default.
• W40772017 hasConcept C2781413609 @default.
• W40772017 hasConcept C42219234 @default.
• W40772017 hasConcept C43376680 @default.
• W40772017 hasConcept C71924100 @default.
• W40772017 hasConcept C86803240 @default.
• W40772017 hasConceptScore W40772017C141071460 @default.
• W40772017 hasConceptScore W40772017C145600735 @default.
• W40772017 hasConceptScore W40772017C18903297 @default.
• W40772017 hasConceptScore W40772017C2779448229 @default.
• W40772017 hasConceptScore W40772017C2781413609 @default.
• W40772017 hasConceptScore W40772017C42219234 @default.
• W40772017 hasConceptScore W40772017C43376680 @default.
• W40772017 hasConceptScore W40772017C71924100 @default.
• W40772017 hasConceptScore W40772017C86803240 @default.
• W40772017 hasLocation W407720171 @default.
• W40772017 hasOpenAccess W40772017 @default.
• W40772017 hasPrimaryLocation W407720171 @default.
• W40772017 hasRelatedWork W1507570395 @default.
• W40772017 hasRelatedWork W1544453927 @default.
• W40772017 hasRelatedWork W1999986707 @default.
• W40772017 hasRelatedWork W2022299018 @default.
• W40772017 hasRelatedWork W2073934019 @default.
• W40772017 hasRelatedWork W2152690676 @default.
• W40772017 hasRelatedWork W2166275595 @default.
• W40772017 hasRelatedWork W2413521266 @default.
• W40772017 hasRelatedWork W2987799904 @default.
• W40772017 hasRelatedWork W40772017 @default.
• W40772017 hasVolume "52" @default.
• W40772017 isParatext "false" @default.
• W40772017 isRetracted "false" @default.
• W40772017 magId "40772017" @default.
• W40772017 workType "article" @default.